38112003: 1 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
ett	Is a	General adjectival modifier	false	Inferred relationship	Some
ett	Is a	siffra	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	3
Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	3
Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	2
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	2
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	3
Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely porcine isophane insulin 70 unit/1 milliliter and porcine regular insulin 30 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	2
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	3
Nystatin 100000 unit oromucosal lozenge	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Nystatin 100000 unit oromucosal lozenge	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Nystatin 100000 unit vaginal tablet	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Nystatin 100000 unit vaginal tablet	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely tuberculin purified protein derivative 10 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Tuberculin purified protein derivative 1000 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Tuberculin purified protein derivative 1000 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely follitropin alfa 75 unit/1 vial powder for conventional release solution for injection (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely follitropin alfa 37.5 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely tuberculin purified protein derivative 100 unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Benzathine benzylpenicillin 900000 unit/mL and procaine benzylpenicillin 300000 unit/mL suspension for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Tuberculin purified protein derivative 50 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Tuberculin purified protein derivative 50 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely interferon alfa-n3 5 million unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely epoetin alfa 3000 unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Follitropin alfa 300 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Follitropin alfa 300 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely salmon calcitonin 200 unit/1 actuation conventional release nasal spray (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Urofollitropin 150 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Urofollitropin 150 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Epoetin alfa 20000 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Epoetin alfa 20000 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely porcine isophane insulin 100 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely bemiparin sodium 22500 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely bemiparin sodium 22500 unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Bemiparin sodium 40000 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Bemiparin sodium 40000 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely human isophane insulin 70 unit/1 milliliter and recombinant human regular insulin 30 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely human isophane insulin 60 unit/1 milliliter and recombinant human regular insulin 40 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely insulin lispro 50 unit/1 milliliter and insulin lispro protamine 50 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely human isophane insulin 90 unit/1 milliliter and recombinant human regular insulin 10 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely human isophane insulin 85 unit/1 milliliter and recombinant human regular insulin 15 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Antidiuretic hormone 20 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Antidiuretic hormone 20 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Benzathine benzylpenicillin 600000 unit/mL suspension for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Benzathine benzylpenicillin 600000 unit/mL suspension for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Urokinase 50000 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Urokinase 50000 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely porcine regular insulin 100 unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Bovine isophane insulin 100 unit/mL suspension for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Bovine isophane insulin 100 unit/mL suspension for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely human isophane insulin 80 unit/1 milliliter and recombinant human regular insulin 20 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Hepatitis B surface antigen immunoglobulin 312 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely bovine hyaluronidase 150 unit/1 milliliter conventional release solution for injection (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
RimabotulinumtoxinB 5000 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
RimabotulinumtoxinB 5000 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely human isophane insulin 50 unit/1 milliliter and recombinant human regular insulin 50 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Human anti-D immunoglobulin 1250 unit/mL solution for injection	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Human anti-D immunoglobulin 1250 unit/mL solution for injection	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely human isophane insulin 75 unit/1 milliliter and recombinant human regular insulin 25 unit/1 milliliter conventional release suspension for injection (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely fluvoxamine maleate 150 milligram/1 each prolonged-release oral capsule (clinical drug)	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely fluvoxamine maleate 150 milligram/1 each prolonged-release oral capsule (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	1
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	3
Product containing precisely carbinoxamine maleate 800 microgram/1 milliliter and dextromethorphan hydrobromide 3 milligram/1 milliliter and pseudoephedrine hydrochloride 12 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug)	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	2
Fluvoxamine maleate 100 mg prolonged-release oral capsule	har nämnarvärde som visar styrka	False	ett	Inferred relationship	Some	1
Fluvoxamine maleate 100 mg prolonged-release oral capsule	räkning av bas i aktiv ingrediens	False	ett	Inferred relationship	Some
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	3
Product containing precisely brompheniramine maleate 400 microgram/1 milliliter and dextromethorphan hydrobromide 2 milligram/1 milliliter and phenylpropanolamine hydrochloride 2.5 milligram/1 milliliter conventional release oral solution (clinical drug)	har nämnarvärde som visar koncentrationsstyrka	False	ett	Inferred relationship	Some	2

Start Previous Page 187 of 215 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
64719019	One	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442104013	1 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442105014	1	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
143801000052115	ett	sv	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Sweden NRC maintained module (core metadata concept)